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The Embryology 
Kidney 
of the 
HENRY SCHMIDEK, '63 
INTRODUCTION 
The human k id ney has traditi onally been considered as developing from two 
excretory organs which arise, and then disappear, with a third organ form-
ing the ecretory tissue of the pe rmanent kidney. This concept has now been 
repl aced by one which views the pronephric. mesonephric, and metanephric o rgans 
as th ree arbitra ry reg ions in a cont inuous nephrogenic cord, all levels of wh ich 
develop tubul es openin~ into the same: lo n~itudinal duct carrying excretory 
products to the cloaca. The objc:ct of thi paper is to review these two concepts of 
the deve lopment of the kidney. 
EMBRYONIC MESODERM 
The embryo has three primary germ 
layers, the ectoderm, mesoderm and endo-
derm. The mesoderm divides to form the 
( 1) paraxial mesoderm which forms the 
vertebrae, paraxial muscles, and as oc-
iated dermis ; 
( 2) intermediate cell mass which forms the 
kidneys, and internal genital organs ; 
(3) lateral sheet mesoderm which splits into 
two layers, one applied to the ectoderm 
to form the body wall (somatopleure) , 
and the inner one to the endoderm of 
the gut and yolk sac (splanchnopleure) . 
The intermediate cell mass is a part of the 
mesoderm connecting paraxial mesoderm 
with the lateral sheet mesoderm, and this 
divides early in development into two long-
itudinal ridges projecting into the celomic 
cavity. The medial is the genital ridge and 
gives rise to the gonads, and the lateral 
forms the nephrogenic cord which gives rise 
to the kidneys. 
CLASSICAL THEORY 
The three organs which appear during 
the development of the kidney arise in a 
cranial-caudal sequence from the nephro-
genic cord. 
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Pronephros 
The earliest and simplest organ is the 
pronephros, represented in the embryo 
duri ng the fourth week as a series of 
cords in the future cervical region and 
upper thoracic segments. The lateral part 
of the cord turns caudally and comes in 
contact with the succeeding segment fusing 
with it to form a longitudinal duct ex-
tending to the anterior part of t he cloaca. 
The medial parts of the pronephric ducts 
are very rudimentary and degenerate in 
the fifth week. The duct persists to become 
the duct of the mesonephros. 
Mesonephros 
The mesonephros in the second month 
begins to form from spherical masses in 
the nephrogenic cord which become hol-
low and form vesicles. The mesonephric 
duct, now termed the Wolffian Duct, runs 
along the side of these vesicles and canal-
izes. The vesicles differentiate into coiled 
tubes which open into the duct and have 
dilated ends which are invaginated by 
blood vessels to form glomeruli. These 
glomeruli are probably functional, but by 
the second half of the second month all 
the mesonephric glomerul i and most of the 
tubules undergo atrophy in a cranial-
caudal order. Those close to the male 
gonad remain to form the vasa efferentia 
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of the testis. In the female, all parts 
become vestigial. 
Metanephros 
The secretory portion of the permanent 
kidney, the nephron, arises from the caud-
al position of the nephrogenic cord, and 
the collecting tubules, calyx and ureter 
are derived from a bud growing out of the 
W olffian Duct. The ureteric bud takes the 
form of a hollow tube which, shortly after 
its appearance, grows dorsally and cran-
ially. Its tip contacts the undifferentiated 
mesoderm of the nephrogenic cord which 
forms a cap over it, and is pushed cranially 
out of its position in the pelvis. Both the 
bud and the cap bifurcate, the branching 
process being repeated for thirteen genera-
tions. Several of the secondary tubules 
enlarge and incorporate the branches of 
the third and fourth order into t heir walls, 
thus forming nine compartments, each of 
which is a minor calyx. The tubules of the 
fifth order open into each minor caylx as a 
papillary duct and the remaining higher 
orders of tubules constitute the collecting 
tubules. The aggregation of all the tubula r 
trees that drain into a minor calyx comprise 
the pyramid. 
Some of the tissue about the ends of the 
collecting tubules condenses into solid masses 
or spheres which soon form a vesicle. The 
vesicle elongates to form an S-shaped 
secretory tubule, one end uniting with the 
terminal collecting tubule. The blind end 
is invaginated by an afferent arteriole 
from the dorsal aorta. This differentiates 
to form capillary loops of the glomerulus 
and from them the efferent arteriole grows 
outwards. The walls of Bowman's capsule 
grow around to enclose the vascular knot 
except at the point where the arterioles 
enter and emerge. The tubules become 
elongated and twisted and their epithelium 
specializes to perform the secretory and 
resorptive functions of the kidney. 
The kidneys develop in the pelvis and 
migrate to the upper lumbar region, under-
going a rotation of ninety degrees. At all 
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times, the kidney is retroperitoneal in 
position, and by the third fetal month, the 
human kidney is capable of secretion. 
Urine is produced slowly, and voided into 
the amniotic sac. 
HOLONEPHRIC THEORY 
In contradistinction to the classical view, 
the holonephric interpretation of renal 
development differs in its interpretation of 
the development of the excretory ducts and 
of the nephrogenic cord. The holonephric 
interpretation maintains that t here is no 
evidence for the participation of the neph-
ron in the formation of the Wolffian duct, 
rather, that t he duct appears before the 
advent of the tubules, anticipating rather 
than originating from them. The evidence 
favors the origin of the nephric duct by 
an in sit11 differentiation from the nephro-
genic cord rather than from serial junctions 
of nephrons. The ninth somite marks the 
anterior extremity of the nephric duct; from 
this level it is adjudged to extend as far 
back as the thirteenth or fourteenth somite. 
It frees itself from the parent mesoderm 
and extends as a tapering rod farther and 
farther caudally to reach the cloacal wall 
at the end of the fourth week. 
The classical view held that three organs 
were differentiated in the course of devel-
opment of the kidney. These have been 
set off from one another by various crit-
eria which are denied by the holonephric 
theory. It emphasizes, instead, the grada-
tion of pronephros into mesonephros and 
metanephros over a continuum associated 
with a progressive increase of structural 
complexity along the nephrogenic cord. 
Thus, the pronephros is an adequate func-
tional unit in organisms such as Amph-
ioxus, and may serve as a provisional kid-
ney in fishes and amphibians. It is replaced 
by the mesonephros in these organisms 
since they require a more complex excre-
tory mechanism. In man, the cranial end 
of the nephrogenic cord shows only the 
most rudimentary development so that a 
pronephros no longer exists. At the same 
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time, the lower levels of the nephrogenic 
cord show a steeper structural gradient and 
attain the highest level of complexity. The 
con equence is that the pronephra , meso· 
nephros and metanephros have no real 
significance other than as descriptive term 
for reg ions of the holonephros. 
CONCLUSION 
One may therefore conclude tha-t the 
two theories of renal development differ 
only in interpretation of kidney develop· 
ment of the first four weeks. However, 
after the excretory duct has been formed 
THE IRRITANT EFFECT OF SOAP 
UPON THE NORMAL SKIN 
F. Ray Bettley, F.R.C.P. and Elaine Don-
oghue, M.B., B.S., The British Journal of 
Dermatology, Vol. 72, No. 2, Feb. 1960. 
Patch-test reactions were used to study 
the irritant p roperties of soap. The patch-
test reactions are of the primary irritant 
type and very seldom exhibit the vesicular 
response of allerg ic epidermal hyperten-
sitivity. 
Alkalinity 
A series of 48 hour patch tests using 
a carbonate-hycarbonate buffer of pH10. 7 
produce all negative results. These nega-
tive results may be partly due to the power 
of the skin to neutralize the alkali. It is 
probable that the irritancy of different 
types of soap is not due to pH, at least not 
to pH alone. 
Neutral Soap 
Fatty acid soaps of strong alkalis are 
strongly alkaline in aqueous solution with 
a pH of 9.5 to 10. A close to neutral soap 
has been achieved with the use of a weak 
base triethaooline (TEA) . TEA has a high 
stearic acid content and is composed of 
25% of sodium soap. TEA alone as a 
lotion was not irritant however TEA stear-
ate was found to be irritant. (Ray & Blank 
1940) . 
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and joined to the cloaca, and the nephro-
genic stage discerned, the interpretations 
of subsequent development of the mature 
kidney are identical. 
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Fatty Acids 
Blank (1939) showed that low molecular 
weight fatty acids, especially caprylic and 
capric were more irritant. Oleic, myristc 
and palmi tic were least irri tant. For any 
one fatty acid, irritancy was less with a 
lower pH. It is true in industry that soaps 
made from cocoanut oil, which contains low 
molecular weight fat , are more irritating. 
Detergency 
The detergent property of soap as an 
irritant was studied by the line of a soap-
less detergent consisting chiefly of alkyl 
sulfates (Teepol) in concentrations twice 
those recommended by the manufacturers 
for most purposes. There were only 8 
positive reactions out of 157 cases. How-
ever if Teepol was alkalinized the number 
of negative results was reduced to 85% . 
It was suggested that Teepol increases the 
permeability of the epidermis allowing the 
alkali to exert its irritant effect. 
Conclusions 
(1) pH alone has no irritant effects. 
(2) Irritancy does depend to some extent 
on the molecular weight of fatty acids. 
( 3) Detergency alone is not irritant. 
( 4) TEA stearate is irritant. 
- Ivan H . Bracalenti, '61 
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The Diagnosis 
of Tumors of 
and Treatment 
the Kidney 
STUART KLEIN, '62 
INTRODUCI"ION 
All tumors of the kidney shou ld be con idered malignant until proven 
o therwise. umerous studies have revealed that 9~ per cent of renal tumors 
are malignant. Crrery stated that "malignant renal tumors shou ld be classed with 
syphilis and tuberculosis as among the greatest mimics encountered in cliojcal 
medici ne. By direct pressure, by necrosis and hemorrhage, by extension or by 
meta tasis. they can reproduce the clinical appea.rance of an amazing variety of 
diso rders". 
CLASSIFICATION 
I . Tumors of the renal parenchyma 
(a) Benign 
Cortical adenoma 
Fibroma 
Lipoma 
Myxoma 
Angioma 
Lymphangioma 
Hemangiopericytoma 
Leiomyoma 
Cysts of the kidney 
(b) Malignant 
Adenocarcinoma (Gravitz tumor, 
hypernephroma) 
Nephroma (Wilms' tumor) 
Fibrosarcoma 
Liposarcoma 
Leiomyosarcoma 
Angiosarcoma 
Malignancy elsewhere with sec-
ondary invasion of the kidney 
ll. Tumors of the renal pelvis 
(a) Benign 
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Papilloma 
(b) Maligntlllt 
Papillary transitional cell 
carcinoma 
Squamous cell carcinoma 
Since ade11ocarcinoma, 1uphroma, and 
carcinoma of the renal pelvis are the com-
monest primary tumors of the kidney they 
will be discussed first. 
MALIGNANT TUMORS OF THE 
KIDNEY 
Incidence 
Renal cancers constitute 1.3 per cent of 
all cancers. The incidence is higher in 
males than in females by a ration of 7 to 3. 
Age 
Adenocarcinomas of the renal paren-
chyma and the epithelial tumors of the 
renal pelvis occur almost entirely in adults 
with a maximum incidence between the 
ages of 50 and 60 years. Nephroma is 
most often seen in children from 6 months 
to 5 years of age. 
Signs and Symptoms 
These are four cardinal signs and symp-
toms, which, if found together indicate 
the presence of a malignant renal tumor. 
They are: 
1) pain 
2) hematuria 
3) presence of a mass 
4) a deformed pyelogram. 
U.W.O. MEDICAL }OUllN.AL 
~ I 
.. 
1) Pain 
In about one half of cases these is some 
pain. This is due to : 
a) dot colic 
b) hemorrhage or necrosis of the tumor 
c) local extension. 
2) H emaJ11ria 
This is the most important and dramatic 
symptom. It occurs in about 90 per cent 
of transitional cell growths, 60 per cent of 
epidermoid growths, 50 per cent of adeno· 
carcinomata, and 20 percent of nephro-
mas. The hematuria may vary from the 
microscopic finding of a few cells to 
gross hematuria producing a dark red 
urine. If clots are present they are small 
and are formed in the ureter. Tumors of 
the kidney pelvis bleed early, while those 
of the parenchyma often bleed only when 
they penetrate the kidney pelvis . 
3) Mass 
Tumors can be felt in about 55 per cent 
of patients with renal cancers, but many 
times the tumors develop on the posterior 
surface of the kidney or at the upper 
pole where they are impossible to palpate. 
4) AsymptomaJic 
Occasionally the tumor is quite silent 
and is only discovered: 
a) on physical examination for some 
other complaint 
b) on pyelography for disease of the 
other kidney 
c) at post mortem examination. 
5) Pyrexia 
Pyrexia of unknown origin may be the 
only clinical manifestation of an adeno-
carcinoma. One should suspect this disease 
in people of the right age group with a 
long drawn out low grade fever of 
unknown origin. 
6) Varicocele 
Sudden varicocele especially on the left 
side may occur with these tumors. It is not 
a good prognostic sign. It is produced by 
pressure of the tumor on the spermatic 
MAY, 1961 
vein or stasis of the spermatic vein caused 
by the growth of the tumor into the renal 
vein. 
7) Edema 
A sudden edema of the lower limbs, 
scrotum, penis, and sacral area may occur 
due to tumor obstructing the vena cava. 
8) Symptoms d11e to metastases 
The initial symptom of a malignant 
renal tumor may be due to metastatic in-
vasion e.g. of bone, lung, or brain. 
Diagnosis 
In order to diagnose a kidney tumor one 
must constantly think of the possibility and 
use all the diagnostic procedures available. 
This should include: a) a careft~lly taken 
history including an enquiry into the pres-
ence or absence of the previously mentioned 
signs and symptoms. b) A thoro11gh physical 
examinatio11 should be carried out including a 
general and specific examination. c) Ro11tine 
11rinalysis should be done on all patients and 
check made for hematuria. d) A11 intraven-
olls PJelogram is a valuable diagnostic aid. 
A filling defect in one or more calyces is 
suggestive of tumor. e) Cystoscopic examin-
ati01z, and f) retrograde pyelograms have 
aided the investigation of a possible kidney 
cancer. In recent years the introduction of 
g) renal arteriography and h) presacral 
pnellmonography have aided in the diag-
nosis. Venous puddling on an arteriogram is 
diagnostic of a hypernephroma. The latter 
two procedures should be used as last tools 
for the investigation of a renal cancer since 
there is some danger in their use. i) A Papa-
nicolaotJ smear should be done in suspected 
cases. j) Rarely a laparotomy must be done 
where a kidney malignancy is suspected but 
definite confirmatory evidence is not avail-
able. 
Treatment 
a) S11rgica/ 
Once the diagnosis has been made 
nephrectomy has been and still is the 
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treatment of choice for malignant disease 
of the kidney provided the tumor can be 
removed and the patient can stand the 
surgery. Nephro-ureterotomy is the treat-
ment of renal pelvis carcinoma. 
b) Irradiation 
i. Where there is evidence of invasion 
of perinephric fat or regional lymph nodes 
by a hypernephroma, the patient should 
receive a full dose of radiotherapy. 
ii. Papillary transitional cell ca.rcinoma 
should be irradiated only if there is evi-
dence of invasion of peri-pelvic tissues. 
iii. Radiotherapy is of no value in 
squamous cell carcinoma of the renal pelvis. 
iv. Post-operative irradiation should be 
used in cases of Wilms' tumor. 
c) Palliative 
When neither surgery nor radiotherapy 
are feasible, every attempt should be made 
to keep the patient comfortable. Good 
nursing care as well as analgesics should 
be provided. Tranquillizers are of value in 
decreasing the awareness of pain. 
Prognosis 
a) Squamous cell carcinoma of the 
renal pelvis is always fatal regardless of 
therapy. 
b) In transitional cell carcinoma, the 
survival rate for 10 years is about 40 per 
cent, provided that the bladder and ureter 
are not involved. 
c) In adenocarcinoma of the kidney, the 
5 year survival rate is about 40 per cent 
and the ten year survival about 20 per cent. 
d) The five year survival rate for 
Wilms' tumor is approximately 10-15 per 
cent. 
BENIGN TUMORS OF THE KIDNEY 
EXCLUDING CYSTS 
These are quite uncommon and rarely 
make themselves known before autopsy 
because they fail to develop in size suf-
ficiently to cause symptoms. The adenoma 
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has the potentiality to develop into a carcin-
omo and therefore is the most important of 
these tumors. Adenomas are minute greyish-
white or yellowish nodules located in the 
kidney cortex. 
CYSTS OF THE KIDNEY 
Two varieties of cystic disease affect the 
kidney : a) simple or "solitary" cysts and 
b) polycystic disease. 
a) Simple cysts 
They are usually unilateral and single 
but may be multiple! and multilocular. They 
are filled with dear fluid and may en-
croach on the kidney tissue. 
Signs and Symprorns 
Frequently they are symptomless. Often 
they are discovered accidentally by an in-
travenous pyelogram. Pyuria sometimes 
occurs but hematuria is uncommon. 
Diagnosis 
Simple cysts are often similar to solid 
tumors of the kidney and it is sometimes 
impossible to be certain that a solid tumor 
is nnt present until laparotomy. Intra-
venous and retrog rade pyelograms as well 
as renal arteriography aid in the diagnosis. 
No arteries are visible in the mass produc-
ed by a cyst, but with solid tumors there 
is a substantial blood supply. 
Treatment 
Surgery should be performed and the 
cyst excised since it may become malig-
nant. If the cyst has destroyed a great deal 
of renal tissue, nephrectomy may be 
necessary. 
b) Polycystic disease of the kidney 
This is a hereditary disease probably 
due to a failure of proper fusion of the 
collecting system and the excretory tubules. 
The disease occurs in about I in 3000 
hospital admissions and is bilateral in 90 c 
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of cases. The cysts vary in size, and the 
contents vary from dear straw-colored to 
red hemorrhagic fluid. 
Signs and Symptoms 
There may be no symptoms for many 
years. However, as renal damage progres-
ses, the patient may develop hematuria, 
pain, or a palpable mass. Other signs of 
renal failure eventually develop, such as 
azotemia, nausea, vomiting, and hyper-
tension. The urine specific gravity 
approaches 1.010. 
Diagnosis 
Bilateral renal enlargement is suggestive 
of polycystic disease. Accurate diagnosis, 
however, is seldom possible without pyelo-
graphy. On intravenous pyelography dil-
ated and flower-like calyces with rounded 
pressure defects are seen. Retrograde 
pyelograms should be avoided because of 
the danger of infection. 
Treatment 
These patients should be treated con-
servatively. They should be maintained in 
good general health and attempts should 
be made to protect them from infections. 
Indications for surgery are: 
1) malignant tumor in the polycystic 
kidney 
2) severe uncontrollable bleeding 
3) fulminating infection 
4) serious obstruction 
5) severe pain. 
Most of these patients die in the fourth or 
fifth decade, usually in uremia. 
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SARCOMAS OF THE RENAL 
PARENCHYMA 
These are rare and have a worse prog-
nosis than renal carcinoma. They may 
develop from any of the connective tissue 
elements of the kidney. The treatment of 
such a lesion is nephrectomy or even more 
radical surgery, if necessary, to remove the 
tumor. 
MALIGNANCY ELSEWHERE WITH 
SECONDARY INVASION OF THE 
KIDNEY 
The kidney is a common site for second-
ary deposits from other malignancies 
especially carcinoma of the breast, lung, 
and cervix, as well as malignant melanoma. 
BENIGN TUMORS OF THE RENAL 
PELVIS 
The only important one is a papilloma. 
However, it is pre-malignant and should 
be considered to be a low grade transitional 
cell carcinoma. Treatment should consist 
of nephro-ureterotomy. 
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Renal Hypertension 
RICHARD REDINGER, '62 
INTRODUCfiON 
The causes of hypertension are variable, often obscure and may be 
mul tiple in one patient . H owever, definite etiolo,~:y can be traced out in such 
conditions as nephritis, pheochromocytoma, coarctation of the aorta, Cushi ng's 
syndrome, and primary aldosteronism. Where no definite cause can be found, the 
condition is ca ll ed essentia l hypertension. Here, pharmacological therapy at bes t 
may only keep the hypertension under control fo r an indefinite period of time. 
Ho ' ever. when hypertension is due to renal disease the chance for complete 
cu re i excell ent if the condition i amenable to surgery. 
HISTORY 
One of the first physicians to observe a 
close relationship between renal disease 
and its effect on the systemic circulation 
was Bright. At autopsy, he observed that 
in cases of constricted kidneys, the heart 
was often greatly enlarged. He supposed, 
therefore, that the cardiac pathology was 
due to some obstruction to the systemic 
circulation. Pathology of the kidney was 
often incriminated thereafter as a cause of 
this obstruction. Indeed, until the concept 
of essential hypertension, the opinion was 
widespread that hypertension was a direct 
result of renal disease. The pendulum then 
swung the other way as the clinical picture 
of essential hypertension was realized, and 
some claimed that renal disease in itself 
never caused hypertension . 
More recently, Goldblatt's classical ex-
periments have led to renewed and in-
tensive research into the problem of renal 
hypertension. At first , the results of Gold-
blatt's experiments led to inflated enthus-
iasm for the success of unilateral nephrec-
tomy in patients with all types of hyper-
tension. A period of reserve followed when 
it was discovered that relatively few 
patients were cured by this type of surgery. 
Indeed, it was felt by many that renal 
hypertension was rare. However, in the 
last decade, renewed intere t by workers in 
this field such as Howard, Burst and 
Poutasse has brought forth very encour-
aging results. 
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INCIDENCE 
It is estimated that one quar,ter of the 
adult population between the third and 
seventh decades is afflicted by hypertensive 
vascular disease. However, the condition 
known as renal hypertension is not nearly 
as widespread . Indeed, it is often very 
difficult to discover. In the past, it has 
been estimated that two and one half per 
cent of all hypertension is associated with 
urological disease. However, recent reports 
by workers such as Poutasse indicate that 
the incidence may be up to ten times this 
amount. Much of the controversy to-day 
concerning the question of renal hyper-
tension may be attributed to the difficulty 
in determining whether the hypertension 
was caused by renal disease in the begin-
ning or whether primary hypertension not 
due to renal disease causes renal damage 
which in turn adds insult to injury by 
aggravating the pre-existing hypertension. 
Perhaps the only concrete evidence af-
forded is in the realm of renal vascular 
disease. The criterion used is the success 
of surgery in alleviating the condition. The 
disadvantages are that not all renal vas-
cular lesions are detected and, further more, 
all are not amenable to surgery. 
The change in atti tude regarding this 
problem is illustrated by the following 
reports. In 1956, Smith stated that "of all 
patients with hypertension probably less 
than two per cent are candidates for renal 
su rgery." 9 In 1959, Poutasse reported that 
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eighty-seven out of three hundred and 
thirty-seven hypertensives were found to 
have occlusive disease of one or both renal 
arteries and so could be considered for 
surgical treatment. Although his cases are 
in part selected, the latter appears 1to be 
much nearer the true incidence and is a 
result of recent advances in investigative 
procedures. 
CLASSIFICATION OF THE ETIOLOGY 
OF RENAL HYPERTENSION 
A. Primary Renal Disease 
1. Infections 
a) Glomerulonephritis- usually 
chronic 
b) Pyelonephritis 
c) Tuberculosis 
d) Syphilis 
e) Collagen disease 
(i) Periarteritis nodosa 
2. Obstructive lesiom 
a) Renal calculus 
b) Hydronephrosis 
3. eoplasia 
a) Solitary cysts 
b) Benign tumors 
(i) Parenchyma 
Fibroma 
Cortical Adenoma 
(ii) Pelvis 
Papilloma 
c) Malignant tumors 
(i) Parenchyma 
Renal Cell Carcinoma 
Embryoma or Wilm's 
Tumor 
(ii) Pelvis 
Papillary Transitional Cell 
Carcinoma 
Squamous Cell Carcinoma 
4. Congenital Abnormalities 
a) Polycystic di ease 
b) Hypoplasia 
5. Infiltrations 
a) Amyloidosis 
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6. T ramna 
a) Crush syndrome-with fibrosis 
B. Renal Vascular Disturbance 
This is now thought to be more com-
mon than formerly and is particularly 
significant because it is often amenable to 
surgery. 
se. 
l. Extrinsic Forces 
a) Aortic Aneurysm 
b) Retroperitoneal Tumors 
2. b 1trinsic Forces 
Interference with renal circulation per 
a) Embolism 
b) Thrombosis 
c) Arteriosclerotic Plaques 
d) Developmental Defects (fibrous 
intimal proliferation) 
e) Aneurysm 
f) Syphilitic arteritis 
THEORIES OF THE PATHOGENESIS 
OF RENAL HYPERTENSION 
The Goldblatt Kidney 
In 1933, Goldblatt experimentally pro· 
duced renal hypertension in a dog by the 
partial occlusion of one or both renal 
arteries. Since then, modifications of this 
experiment have been carried out with 
variable success. Many theories to explain 
renal hypertension have also been advo-
cated. The most popular is the renal pres-
sor system which is explained as follows. 
Renal substrate or hypertensinogen, 
which is an alpha-2 globulin produced in 
the liver, normally circulates throughout 
the vascular system. Renin is a proteolytic 
enzyme formed in the tubule cells of the 
kidney and released from them in increas-
ed amounts when renal circulation is dis-
turbed. It is distinguished by its specificity 
in attacking the above substrate to form 
the pressor substance angiotonin or hyper-
tensin. Renin splits the large molecule 
hypertensinogen to liberate the polypeptide 
angiotonin. It is speculated that angio· 
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tonin acts directly on the cardio-vascular 
system to cause the heart to constrict. 
Arterial hypertension and arteriolar con-
striction balance in such a way that peri-
pheral blood flow is unchanged but renal 
flow is often diminished. This may result 
in damage i.e. ischemia, to the kidney 
itself. 
Further experimentation shows that the 
normal kidney contains, in greater concen-
tration than most other tissues, proteolytic 
enzymes called angiotonases. The latter 
have the propertty of inactiviating or des-
troying angiotonin. Perhaps renal hyper-
tension may also be produced when a dam-
aged kidney cannot adequately cope with 
angiotonin . It is uncertain whether the 
renal pressor system plays a part in the 
regulation of blood pressure under ordin-
ary circumstances. However, support for 
such a theory in the pathogenesis of renal 
hypertension is given by the following 
work. Recently, Merrill has reported the 
success of transplantation of kidneys in 
identical twins in lowering hypertension. 
It is interesting to note that when t he 
kidney is first transplanted, the hyperten-
sion does not decrease since the recipient's 
diseased kidneys are left in. However, the 
hypertension later declines when bilateral 
nephrectomy of the diseased kidneys 
occurs and only the healthy kidney is left 
in. This indeed supports the theory that 
some sort of pressor system is set up by the 
diseased or damaged kidney. 
Other pressor systems as well as varia-
tions in nervous and vascular controls may 
also influence ,the course of hypertension 
in man. A pressor mechanism may be in-
volved in both essential and malignant 
hypertension. It is thought that the 
process of essential hype-'"tension may 
lead to an obstructive lesion due to an 
atherosclerotic plaque in the renal vascular 
system. This 'then brings the renal mechan-
ism into play so that the hypertension may 
suddenly increase and malignant hyperten-
sion result. 
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CLINCAL FEATIJRES OF RENAL 
HYPERTENSION 
There is no characteristic set of symp-
toms associated with hypertension due to 
renal abnormalities. The symptoms are 
those protean ones characteristic of sus-
tained hypertension. 
Nervousness, irritability, loss of energy, 
easy fatiguability and insomnia are earlier 
signs. Headaches, dizziness, visual distur-
bances, and impairment of memory and 
concentration are later signs. Other distur-
bances may complicate the picture as well, 
such as hypertensive heart disease, further 
cerebral manifestations and aggravated 
renal pathology. 
The history may indicate renal hyper-
tension secondary to some infection affect-
ing the kidneys. A small number of pa-
tients may relate a history of trauma over 
the lumbar region. A history of flank pain 
is always significant in cases of emboliza-
tion. However, often the first indication of 
any trouble i the discovery of an abnorm-
ally high blood pressure. Further physical 
examination may reveal the presence of 
tenderness over the kidney area. On auscul-
tation, a bruit may be heard over the upper 
abdomen suggestive of renal artery 
stenosis. 
INVESTIGATION OF PATIENTS 
WITH SUSPECTED RENAL 
HYPERTENSION 
As always, a thorough history and phys-
ical examination must be done. Renal 
hypertension is only suspected after such 
conditions as Cushing's syndrome, pheo-
chromocytoma, coarctation of the aorta, 
primary heart disease, some neurogenic 
disturbances, and thyrotoxicosis are ruled out 
and indications for primary renal disease or 
renal vascular occlusion are present. It is 
then that a thorough cardiac and renal 
work-up must be done. 
CARDIAC INVESTIGATION 
Special attention must be paid to heart 
size and electrocardiographic findings . 
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Blood pressure levels must be recorded 
over a sufficient period of time to note if 
there is a fixation of the blood pressure. 
RENAL INVESTIGATION 
It must be determined whether the renal 
disease is due to vascular disturbance or 
primary renal disease itself. A general renal 
work-up would include the following 
screening procedures : 
X-ray-flat plate 
Intravenous pyelogram 
Retro-grade pyelogram 
Cystoscopy 
These tests will indicate any disparity 
in size, position, number or form of the 
kidneys. They will also illustrate congenital 
abnormalities as well as obstructive lesions 
of any cause that may exist . 
Renal Function Tests 
BUN 
NPN 
PSP excretion 
Creatine secretion 
Na +, K + excretion 
Urinary sediment 
Twenty-four hour proteinuria 
Investigation of Urinary Tract Bacteria 
Culture and sensitivity 
especially E. Coli, 
Staphylococcus, 
Streptococcus, 
Pseudomonas, 
Tuberculin tests 
skin tests, 
culture, 
guinea pig innoculation 
By this time, definite pathology of one 
or both kidneys may be proven. However, 
negative results do not necessarily rule out 
renal vascular disease. 
Indications of Renal V ascu1ar Disease 
1. Hypertension of sudden onset partic-
ularly if the patient is under thirty-five 
years of age or over fifty-five and in whom 
essential hypertension becomes malignant in 
form. 
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2. Patients with no family history of 
hype11tension and in whom there is a fix-
ation of blood pressure for a definite 
period of time. 
3. Patients developing hypertension after 
an episode of flank or abdominal pain 
suggestive of embolization. 
4. Patients with a history of subactue 
bacterial endocarditis or mitral stenosis with 
fibrillation . 
5. Patients whose intravenous pyelo-
grams suggest certain abnormalities. 
6. Patients whose hypertension is not due 
to nephritis, pheochromocytoma, coarcta-
tion of the aorta, or Cushing's syndrome 
unless there are other counter indications 
such as age or other infirmities. 
Diagnostic Tests 
The diagnostic test to determine renal 
vascular disease is aortography. However, 
two more tests may be of aid in evaluating 
patients for aortography. These are as 
follows : 
1. [ III Pick-tJ p 
By this test, both the up-take and excre-
tion by the kidneys can be compared and 
thus any unilateral abnormality may be 
detected. This is a relatively reliable test 
in good hands. 
2. Differential Sodi11m Excreti011 and V ol-
mne Excretion St11din 
(Howard test) 
Retrograde catheterization may indicate 
a reduction in fluid excretion per minute 
volume or sodium excretion per minute 
volume in one kidney. 
This test is not too reliable since a 
normal test may be found , and difficulties 
in manipulation may occur. 
Aortography 
Although this is the diagnostic test for 
renal vascular disease, it must be realized 
that there is considerable risk involved in 
the procedure. There are two methods of 
aortography. 
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1. Translumbar intra-aortic injection of 
opaque material. 
2. Transfemoral artery catheterization. 
This test is the safer of the two. 
Management 
Whenever a vascular lesion can be dem-
onstrated or unilateral kidney disease can 
be proven, surgery is the treatment of 
choice. Nephrectomy, partial kidney re-
section, arterial or venous by-passes or 
graft in-lays may be performed. 
Medical management is reserved for 
those cases in which surgery is contra-
indicated. It follows the lines of treatment 
of essential hypertension. 
PROGNOSIS 
Where surgery is the treatment of choice 
the prognosis for cure is excellent. 
CONCLUSIONS 
1. Renal hypertension is a definite disease 
and under certain conditions it is amenable 
to surgery. These are in definite un ilateral 
renal disease and in renal vascular occlusion. 
2. Aortography is the method of diagno-
sis of renal vascular disease. With better 
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screening tests, selection of patients for 
this procedure is possible. 
3. The ind ications for aortography must be 
considered before performing this procedure, 
(i.e., thorough investigation plus evidence 
of renal vascular disease.) 
4. Since the work of Merrill with trans-
plantation of kidneys in identical twins it 
seems very probable that a pressor system 
is the cause of renal hypertension. 
5. The role of kidney disease in hyper-
tension as a whole is still debatable. 
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A Survey of Newer Diuretics 
ROBERT SOtiTHERN, '62 
INTRODUCI'ION 
The intelligent use of diuretic therapy plays an important role in the man-
agement of a grea t many disease processes. On the other hand, their careless use 
ca n cause an equal amount of damage, which can, in some cases, be fatal . 
D iuretic therapy is indicated in al l cases of edema. Edema is, in some cases. 
lethal, in others g rossly d isab ling. and in all cases it is a dangerous symptom of 
severe underlying disease. Diuretics depend for their ac tivi ty on a sufficient 
number of responsive kidney uni ts. (i .e.) if the kidney is already operating at a 
maximum as in chronic glomerulonephritis, no diuretic can increase that response. 
The effe t of diuretic agents on acid-base balance and on electrolyte balance 
i , in all cases not only significant, but real, and must be carefully observed. 
One of the corrunonest indications for diuretic therapy is in cardiac decompensation 
in conjunction with digitalis administration. where potassium depletion not only 
present a rea l thre:~ t. but can, if unchecked, result in the demise of the patient. 
The purpose of this paper is t0 review briefly, from a clinical standpoint. 
some of the newer diuretic agent advocated for modern therapy, under a broad 
cl ass ifica tion acco rding to their sites of activity in the kidney . 
CLASSIFICATION 
1. Mercurial compounds 
(a) Chloromerodrin (Neohydrio) 
(b) Meralluride (Mercuhydrin) 
(c) Mercumatilin 
(d) Merethoxylene procaine 
2. Carbonic Anhydrase Inhibitors 
(a) Chlorothiazide DeriYaJtives 
(i) Fluomethazide and Hydrofluo-
methazide 
(d) N eptazane 
(c) Disamide 
3. Aldosterone Antagonists 
(a) Spironolactosteroids 
4. Miscellaneous 
(a) Aminometridine 
(b) Hygroton 
MODES OF ACTIVITY 
Mercurial diuretic compounds appear to 
work by combining with the sulphydryl 
groups in the enzymes of the renal tubular 
cells thereby inactivating them and block-
ing the active reabsorption of sodium ion 
which then passes into the urine carrying 
with it its complement of water. 
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Carbonic anhydrase is an enzyme in the 
renal tubular cells effecting the catalysis 
of the reaotion: 
H 20 + CO: '*- H 2C0 8 ~ H+ + Hco;. 
This results in the production of hydrogen 
ion which can be passed into the tubule 
when sodium is reabsorbed thus maintain-
ing the electrical balance between the fil-
trate and the eel.!. When this enzyme is 
blocked, hydrogen ion is no longer pro-
duced in the quantity necessary, sodium 
cannot be replaced with an ionic equivalent 
and cannot therefore be reabsorbed, pas-
sing into the urine with its complement of 
water. 
Aldosterone is the mineralocorticoid 
secreted by the adrenal cortex which has 
two main effects in the body: 
( 1) it acts on the mechanisms of the 
tubule cells to promote the excretion 
of potassium ion and the reabsorption 
of sodium ion. 
(2) it is believed to have a direct effect 
on the smooth muscle of the arteriole, 
causing contraction and resulting in 
an increase in blood pressure. 
Aldosterone antagonists, though still be-
ing investigated, are believed to promote 
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diuresis by blocking the effect at the renal 
tubular cell. Some investigators feel that 
there may be some activity at the arteriolar 
level which makes them of use in the 
management of some forms of hyperten-
ston. 
INDIVIDUAL DISCUSSION 
( 1) Mercurials 
(a) Chloromerodrin (Neohydri11 ) 
(N.N.R.) (B.P.C.) 
This is an organic mercurial compound 
which has been found to be more useful 
orally than any other mercurial. It is indi-
cated in recurring cardiac and nephrotic 
edema and hepatic ascites. It has been used 
to initiate diuresis, but its greatest effect 
has been found when being used as a sup-
plement to parenteral diuretic therapy. 
Like most other mercurial compounds by 
the oral route, undesirable side reactions 
are not uncommon, including dermatitis 
stomatitis, colic, diarrhea and gastro-intest-
inal upset. Diuresis is maintained at its 
optimum on 55 to 110 mgms. per day in 
divided doses. 
(b) Meralluride Sodium (Merc11hydrin) 
(N.N.R.) (B.P.C.) 
This compound, as produced, is a mix-
ture of an organic mercurial and the 
xanthine, theophylline. This drug cannot 
be given orally, as it is destroyed by the 
gastro-intestinal enzymes, being given pre-
ferably intramuscularly. It is frequently 
given intravenously and has been given 
subcutaneously where it causes painful re-
actions. On intramuscular injection, it does 
not cause pain at the injection site. It is 
well tolerated systemically by most patients 
The distinguishing characteristic of 
Meralluride is that it need be given only 
twice weekly to maintain its optimum 
diuretic effect. It is given as 1 to 2 c.c. of 
a solution containing 130 mgms. of Mer-
alluride Sodium and 10 mgms. of ,theo-
phylline per c.c. Undesirable side reactions 
are very rare. 
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(c) Mercumatilin (N.N.R.) 
This drug consists of mercumallylic acid 
and theophylline in molecular proportions. 
It is effective on oral administration, and 
should be used only as an adjunct to the 
parenteral administration of the sodium 
salt. 
Mercumatilin Sodium is prepared by 
adding just enough sodium hydroxide to 
effect solution. The resulting product dif-
fers from other mercury-theophylline com-
pounds only in structure. It is given intra-
venou ly, or, preferably, intramuscularly. 
Injection does produce some local irrita-
tion. As idiosyncrasies t o this drug are not 
uncommon, no more than 0.5 c.c. should 
be administered initially, following which 
2.0 c.c. may be given intramuscularly bi-
weekly. The sodium alt is marketed in a 
solution containing 0.132 grams per c.c. 
(d) Merethoxylline Procaine ( N .N .R.) 
This drug is a mixture of 1 mol. of the 
procaine salt of Merethoxylline and 1.4 
mols., of anhydrou theophylline, and has 
approximately the same properties and uses 
as the other mercurial diuretics. The pro-
caine component minimizes discomfort to 
the patient as this drug is irritating and is 
administered intramuscularly, rarely intra-
venously or subcutaneously. If given sub-
cutaneously, it must be injected deeply, as 
superficial injections are very irritating. 
This drug must be used with caution, 
and has several specific contraindications: 
(1) sensitivity to mercury, theophylline, 
or procaine 
(2) acute glomerulonephritis 
(3) ulcerative colitis 
( 4) gouty diathesis. 
It must be administered with great caution 
in benign prostatic hypertrophy where 
distension of the bladder may precipitate 
obstruction, or when the B.U.N. exceeds 
60 - 100 mgms. per 100 c.c. J,t should be 
discontinued immediately if albuminuria, 
hematuria or oliguria appear. 
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2. Carbonic Anhydrase Inhibitors 
(a) Chlorothiazide derivatives 
(i) Fluomethazide and Hydrofluometh-
azide 
Like chlorothiazide and hydrochloro-
thiazide, these compounds are essentially 
the same in activity, except that hydrofluo-
methazide is approximately ten times as 
potent as fluomethazide alone. These com-
pounds act at the tubular cell level to in-
hibit the reabsorption of filtered ions. Both 
compounds have a rapid onset, and a dura-
tion of from 10 to 16 hours per single 
dose. Following the administration of a 
single dose, there appear to be two peaks 
of activity, one at 4 hours and the other 
at 9 hours after administration. The first 
peak may be associated with a greater 
excretion of potassium ion. In cases with 
cirrhosis and ascites, their activity appears 
to be prolonged, in some cases, to almost 
24 hours. 
In those cases of prolonged therapy, 
sodium excretion remains strikingly eleva-
ted throughout the duration of therapy; 
potassium excretion is initially elevated. 
Bicarbonate excretion is not significantly 
elevated by these compounds. This does 
not exclude electrolyte imbalance which is 
a real possibility, and, in some cases, hypo-
kalemia may occur which c.an be managed 
by the careful administration of potassium 
supplements. 
These drugs can be used anywhere that 
diuretic therapy is indicated, but have been 
found to be of less value in pulmonary 
heart disease due to their interference with 
adequate renal circulation as indicated by 
an elevated blood urea nitrogen level. 
The most dangerous side effect encount-
ered so far is potassium depletion, but 
dermatitis, gastrointestinal upsets and 
purpura have been reported. 
(b) Neptazmu 
This is a carbonic anhydrase inhibitor 
closely related to acetazolamide (Diamox), 
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its in vitro activity being l.3 to 1.6 times 
that of Diamox. 
Its most useful effect has been found to 
be its ability to lower the intraocular tension 
by inhibiting the production of aqueous 
humor by the ciliary body. Diamox has 
also been used to some extent for thi 
effect, as have most other carbonic anhy-
drase inhibitors, but this compound lowers 
the tension significantly in doses 1/3 to 
1/5 that of Diamox. This fall in pressure 
comes on in one to two hours and is 
maintained for up to 18 hours following 
the administration of a single dose. 
Undesirable side effects include vague 
gastro-intestinal and genito-urinary upsets 
and one case of paresthesia of the face and 
limbs has been reported. 
(c) Disamide 
The activity of this drug resembles that 
of acetazolamide and chlorothiazide in that 
it appears to inhibit carbonic anhydrase . 
Its main advantage is that it does not, 
in most cases, give rise to marked hypoka-
lemia, alleviating to some extent the neces-
sity for intensive potassium supplement 
therapy. 
Its main side effects are cerebral in 
origin, with reports of severe paresthesia 
of the face, hands and feet, difficulty in 
verbal expression, and an inability to cal-
culate. This compound also possesses some 
anticonvulsant activity experimentally and 
has been used on occasion in the manage-
ment of some cases of epilepsy. The dis-
turbing cerebral effects are believed to be 
due to carbonic anhydrase inhibition in the 
substance of the brain. 
(3) .. Aldosterone Antagonists 
(a) Spir01wlactosteroids 
This group of compounds seems to have 
the unique property of antagonizing the 
peripheral effects of the hormone, aldo-
sterone, thereby promoting potassium re-
tention at the same time as increasing 
sodium loss. Therapeutically, the effect is 
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usually a weak one in the doses used at 
present, but, when combined with other 
drugs, a really useful loss of edema fluid 
can be obtained without the danger of 
severe potassium depletion. 
Some workers believe that aldosterone 
production by the adrenal cortex is abnor-
mally high in essential hypertension, hence 
it may prove to be of some use in this 
disease. The changes are more marked when 
aldosterone production is first stimulated 
by dietary sodium restriction. The absence 
of any activity on adrenalectomized sub-
jects would seem to support the theory that 
the compounds so far produced do not 
have any independent activity on the renal 
tubule, since they do not act in the absence 
of aldosterone. 
The use of this group of compounds is 
still quite limited, and for the most part, 
still in the experimental stage. 
( 4) Miscellaneous 
(a) H ygroton 
Although this compound is a carbonic 
anhydrase inhibitor to some extent, its 
activity in this respect is only 1/ 11 that 
of acetazolamide and chlorothiazide and 
this activity does not appear to bear any 
relationship to its diuretic activity. Its site 
of action is, however, in the renal tubules, 
where it blocks sodium reabsorption. 
It is completely absorbed by mouth, but 
slowly, due to its low solubility. Ninety 
per cent of an oral dose is excreted un-
changed in the urine within 24 hours after 
administration. 
A single dose of 25 mgm. in the patient 
with edema increases sodium excretion by 
140% and the excretion of chloride is 
equal to that of sodium. The excretion of 
potassium is said to be minimal. In the 
healthy subject, its effect can still be seen 
24 hours after the administration of a 
single dose and in the patient with edema, 
this effect may be prolonged for almost a 
day beyond that. 
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It has only slight alkalinizing activity on 
the urine, so it does not favor renal lithia-
sis. The only undesirable side effect noted 
to date is a transient loss of potassium 
(again a real threat) which can be con-
trolled with the judicious use of potas-
sium supplements. The prolongation of 
diuresis often interferes with sleep habits. 
Its use is wide, having some effect in 
almost all cases of edema from whatever 
cause, and it has been found to be as 
useful as acetazolamide in reducing the 
intraocular tension of glaucoma. 
(b) Aminometridi11e 
This compound is a synthetic uracil 
derivative and is well tolerated by most 
patients on oral administration. 
Its mode of action is hazy. It is believed 
to inhibit sodium reabsorption in the tub-
ule, with a slight to variable effect on 
potassium excretion. It has no inhibitory 
activity on carbonic anhydrase or on suc-
cinic dehydrogenase, and it does not affect 
the renal blood flow or glomerular filtra-
tion rate to any significant degree. It does 
not alter the urinary reaction, nor affect 
systemic acid-base balance to any extent. 
Its diuretic metabolic fate is very poorly 
understood and there are no known con-
traindications to its use. Its only side 
effect known to date is nausea and vomit-
ing seen in 20 - 30 of patients. 
Its isomer, Isometradine, is a little less 
irritating, causing gastro-intestinal upset in 
only 10- 15% of patients. Otherwise it is 
exactly the same in activity. 
These compounds have been found to be 
useful in some patients who have failed 
to respond to mercurial therapy and to 
have their maximum activity in those with 
increased serum sodium. 
The prime indication is cardiac decom-
pensation. Those with attending ascites, 
pulmonary edema, orthopnea or dyspnea 
do not respond well to initial ·therapy. 
These excess fluids should first be rapidly 
mobilized with mercurials, then kept 
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edema-free with these drugs. It must be 
borne in mind tha t these compounds are 
to be used only as adjunct to digitalis 
therapy and restricted sodium diet. T hey 
have been tried in hepatic ascites and in the 
nephrotic syndrome where they have been 
found to promote only moderate diuresis. 
SUMMARY 
Several newer diuretic compounds are 
class ified according to their sites of activity 
in promoting naturesis. Each is discussed 
in turn, pointing out its specific usefulness, 
specific side effects, and its distinguishing 
characteristics. 
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